Troy E. Wilson - Jun 2, 2023 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
President and CEO, Director
Signature
Teresa Bair, attorney-in-fact for Troy E. Wilson
Stock symbol
KURA
Transactions as of
Jun 2, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 05:06 PM
Previous filing
Feb 21, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Other $0 -8.39K -100% $0.00* 0 Jun 2, 2023 by Red Fish Blue Fish Revocable Trust F1
transaction KURA Common Stock Other $0 +8.39K +0.75% $0.00 1.13M Jun 2, 2023 by One Fish Two Fish Revocable Trust F1
transaction KURA Common Stock Other $0 -41.3K -3.64% $0.00 1.09M Jun 2, 2023 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -213K -19.45% $0.00 880K Jun 2, 2023 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -300K -34.08% $0.00 580K Jun 2, 2023 by One Fish Two Fish Revocable Trust F2
transaction KURA Common Stock Other $0 -300K -51.71% $0.00 280K Jun 2, 2023 by One Fish Two Fish Revocable Trust F1
transaction KURA Common Stock Other $0 +300K $0.00 300K Jun 2, 2023 by Lorax Charitable Remainder Unitrust F1
transaction KURA Common Stock Other $0 -28K -91.62% $0.00 2.56K Jun 2, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person.
F2 This transaction represents a transfer of shares of common stock without consideration from a grantor trust established by the reporting person to another trust established by the reporting person. As a consequence of this transfer, the reporting person will no longer have beneficial ownership of the shares.